BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28925068)

  • 1. When and how can nephrologists treat hepatitis C virus infection in dialysis patients?
    Davis MI; Chute DF; Chung RT; Sise ME
    Semin Dial; 2018 Jan; 31(1):26-36. PubMed ID: 28925068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming a treatment barrier in treating hepatitis C in dialysis patients.
    Lapumnuaypol K; Feyssa E
    Semin Dial; 2018 Mar; 31(2):193. PubMed ID: 29405426
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C virus infection in dialysis patients.
    Khedmat H; Amini M; Ghamar-Chehreh ME; Agah S
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):1-8. PubMed ID: 24434375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
    Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
    Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
    Vallet-Pichard A; Pol S
    Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C treatment in patients with kidney disease.
    Fabrizi F; Aghemo A; Messa P
    Kidney Int; 2013 Nov; 84(5):874-9. PubMed ID: 23823603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatitis C infection among patients with renal failure.
    Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV and the kidney.
    Corouge M; Vallet-Pichard A; Pol S
    Liver Int; 2016 Jan; 36 Suppl 1():28-33. PubMed ID: 26725894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
    Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
    Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan.
    Hu TH; Su WW; Yang CC; Yang CC; Kuo WH; Chen YY; Yeh YH; Chen SS; Tsao YY; Chen KM; Yan SL; Lai JH; Yao CD; Lim CH; Jen HH; Yeh YP; Chen SL; Chen HH; Chen SC;
    Am J Kidney Dis; 2021 Oct; 78(4):511-519.e1. PubMed ID: 33940114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C infections in dialyzed patients].
    Podlasin RB
    Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.
    Chute DF; Chung RT; Sise ME
    Kidney Int; 2018 Mar; 93(3):560-567. PubMed ID: 29325996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH; Kao JH
    J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
    Kamar N; Ribes D; Izopet J; Rostaing L
    Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating hepatitis C virus in dialysis patients: How, when, and why?
    Pagan J; Ladino M; Roth D
    Semin Dial; 2019 Mar; 32(2):152-158. PubMed ID: 30475415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
    Cacoub P; Desbois AC; Isnard-Bagnis C; Rocatello D; Ferri C
    J Hepatol; 2016 Oct; 65(1 Suppl):S82-S94. PubMed ID: 27641990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C infection and the patient with end-stage renal disease.
    Fabrizi F; Poordad FF; Martin P
    Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral treatment and prognosis in patients undergoing maintenance hemodialysis due to hepatitis C virus.
    Zhang W; Yuan Q; Ning J; Li X; Wu A; Xiao X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1332-1337. PubMed ID: 35232901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
    García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
    Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.